A detailed history of Tower Research Capital LLC (Trc) transactions in Abb Vie Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 51,845 shares of ABBV stock, worth $9.33 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
51,845
Previous 50,184 3.31%
Holding current value
$9.33 Million
Previous $8.61 Million 18.95%
% of portfolio
0.28%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $272,138 - $331,087
1,661 Added 3.31%
51,845 $10.2 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $2.86 Million - $3.34 Million
18,464 Added 58.21%
50,184 $8.61 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $34.2 Million - $38.9 Million
-213,794 Reduced 87.08%
31,720 $5.78 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $23.7 Million - $26.7 Million
172,192 Added 234.84%
245,514 $38 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $5.42 Million - $6.27 Million
40,548 Added 123.72%
73,322 $10.9 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $570,190 - $709,564
-4,303 Reduced 11.61%
32,774 $4.42 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $573,957 - $660,997
3,969 Added 11.99%
37,077 $5.91 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $20.5 Million - $24.6 Million
-148,319 Reduced 81.75%
33,108 $5.35 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $10.5 Million - $12 Million
78,204 Added 75.76%
181,427 $24.4 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $21.7 Million - $27.6 Million
-157,771 Reduced 60.45%
103,223 $15.8 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $21.8 Million - $27.1 Million
165,369 Added 172.93%
260,994 $42.3 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $6.93 Million - $8.77 Million
64,533 Added 207.55%
95,625 $12.9 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $6.5 Million - $7.38 Million
-61,097 Reduced 66.27%
31,092 $3.35 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $9.95 Million - $11.1 Million
-94,597 Reduced 50.64%
92,189 $10.4 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $12.4 Million - $13.7 Million
121,468 Added 185.96%
186,786 $20.2 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $2.38 Million - $3.22 Million
29,591 Added 82.83%
65,318 $7 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $411,422 - $482,874
4,789 Added 15.48%
35,727 $3.13 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $1.92 Million - $2.56 Million
26,112 Added 541.07%
30,938 $3.04 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $309,277 - $468,903
4,795 Added 15467.74%
4,826 $368,000
Q4 2019

Feb 07, 2020

SELL
$72.13 - $90.25 $1.24 Million - $1.55 Million
-17,202 Reduced 99.82%
31 $3,000
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $988,471 - $1.19 Million
15,695 Added 1020.48%
17,233 $1.31 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $1.37 Million - $1.76 Million
-20,908 Reduced 93.15%
1,538 $112,000
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $1.65 Million - $1.94 Million
-21,396 Reduced 48.8%
22,446 $1.81 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $85,401 - $105,322
-1,097 Reduced 2.44%
43,842 $4.04 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $2.05 Million - $2.27 Million
-23,008 Reduced 33.86%
44,939 $4.25 Million
Q2 2018

Aug 15, 2018

BUY
$89.78 - $106.23 $5.99 Million - $7.09 Million
66,747 Added 5562.25%
67,947 $6.3 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $1.38 Million - $1.84 Million
-14,963 Reduced 92.58%
1,200 $114,000
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $1.01 Million - $1.11 Million
11,307 Added 232.85%
16,163 $1.56 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $339,191 - $433,252
4,856
4,856 $432,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.